Search for: "KING PHARMACEUTICALS, INCORPORATED" Results 1 - 20 of 29
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jun 2023, 1:09 pm by admin
 Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
12 Oct 2021, 5:12 pm
Cir. 2017) (explaining that “the tenth-digit statistical suffixes . . . are not statutory,” as those suffixes are not incorporated in the HTSUS’s legal text). [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Pharmaceutical Pricing Jaime King, University of California Hastings College of the Law, The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs Marc Rodwin, Suffolk University Law School, Controlling Pharmaceutical Prices: What the U.S. [read post]
2 Nov 2018, 7:32 pm by Schachtman
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989) (“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
7 Mar 2017, 3:16 am by Dennis Crouch
Sweetland, The Federal Trade Commission’s (FTC) Recommendations to the International Trade Commission (ITC):  Unsound, Unmeasured, and Unauthoritative, 2011 Patently-O Patent Law Journal 1 (levi.ftcunsound.pdf) Kevin Emerson Collins, An Initial Comment on King Pharmaceuticals: The Printed Matter Doctrine as a Structural Doctrine and Its Implications for Prometheus Laboratories, 2010 Patently-O Patent Law Journal 111 (Collins.KingPharma.pdf) Robert A. [read post]
2 Jan 2016, 2:51 pm by Thaddeus Mason Pope, J.D., Ph.D.
Next week, the 110th AALS Annual Meeting starts in New York. [read post]
9 Nov 2015, 7:09 am
Back in 2009 – when the blog was still a Bexis/Herrmann operation – we wrote a catch-all punitive damages post entitled (oddly enough) “On Punitive Damages. [read post]
9 Apr 2015, 11:59 am by Lawrence B. Ebert
Chien, Of Trolls, Davids, Goliaths, and Kings: Narratives and Evidence in the Litigation of High-Tech Patents, 87 N.C. [read post]
2 Feb 2015, 2:20 am
For instance: when does the alteration of objects incorporating the protected work involve a new authorisation from the right holder? [read post]
26 Jan 2015, 1:12 pm
Markus Ederer (Secretary of State, German Federal Ministry for Foreign Affairs), and Grand Justice Guixiang Liu (Grand Justice of Second Rank and Executive Member of the Adjudication Committee, the Supreme People’s Court) addressed in the topic “The Rule of Law: Local and Global Perspectives”, subsequent to which Giles White (General Counsel, Jardine Matheson Limited), Vincent Connor (Head of Hong Kong Office and Asian Sectors, Pinsent Masons), and Yi Zhang (Managing Partner,… [read post]
3 May 2014, 8:56 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 89 F.3d 594, 596-98 (9th Cir. 1996) (affirming exclusion of Dr. [read post]
19 Sep 2013, 12:35 pm
Chaudhary worked in various human service organizations including the Young Adult Institute in Queens, NY, the Girls Incorporated of the Greater Capital Region, and Clearview Center, Inc. in Albany, NY. [read post]
12 Apr 2013, 10:48 am by Jason Rantanen
  Because it's a grant by the King, in English history only the King could revoke the patent. [read post]
10 Jun 2012, 1:09 pm by Schachtman
In some instances, especially in studies pharmaceutical adverse outcomes, there is the danger that the hypothesized outcome is also a feature of the underlying disease being treated. [read post]
9 Jan 2012, 4:44 pm by Adrian Lurssen
We're pleased to welcome the following lawyers and law firms to JD Supra, now distributing their legal updates and publications on our law news network:- King & Spalding"Celebrating more than 125 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 800 lawyers in 17 offices in the United States, Europe, the Middle East and Asia. [read post]